Home Healthcare Biotechnology Renal Biomarkers Market

Renal Biomarkers Market Size, Share & Trends Analysis Report By Biomarker Type (Functional Biomarker, Up-regulated Protein, Other Biomarker Types), By Diagnostic Technique (Enzyme-linked Immunosorbent Assay, Colorimetric Assay, Particle-enhanced Turbidimetric Immunoassay (PETIA), Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass, Spectrometry (LC-MS)), By End-User (Hospital, Diagnostic Laboratory, Others) and By Country (U.S., Canada) Forecasts, 2026-2034

Last Updated: July 09, 2026 | Author: Debashree B | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Renal Biomarkers Market, By Biomarker Type 2022-2034 (USD MILLION/ Units)
    1. Functional Biomarker
    2. Up-regulated Protein
    3. Other Biomarker Types
  2. Renal Biomarkers Market, By Diagnostic Technique 2022-2034 (USD MILLION/ Units)
    1. Enzyme-linked Immunosorbent Assay
    2. Colorimetric Assay
    3. Particle-enhanced Turbidimetric Immunoassay (PETIA)
    4. Chemiluminescent Enzyme Immunoassay (CLIA)
    5. Liquid Chromatography Mass
    6. Spectrometry (LC-MS)
  3. Renal Biomarkers Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Hospital
    2. Diagnostic Laboratory
    3. Others
  4. Regional Renal Biomarkers Market
    1. North America
      1. North America Renal Biomarkers Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
      2. North America Renal Biomarkers Market By Diagnostic Technique 2022-2034 (USD MILLION/ Units)
        1. Enzyme-linked Immunosorbent Assay
        2. Colorimetric Assay
        3. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        4. Chemiluminescent Enzyme Immunoassay (CLIA)
        5. Liquid Chromatography Mass
        6. Spectrometry (LC-MS)
      3. North America Renal Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Diagnostic Laboratory
        3. Others
      4. U.S.
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      5. Canada
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
    2. Europe
      1. Europe Renal Biomarkers Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
      2. Europe Renal Biomarkers Market By Diagnostic Technique 2022-2034 (USD MILLION/ Units)
        1. Enzyme-linked Immunosorbent Assay
        2. Colorimetric Assay
        3. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        4. Chemiluminescent Enzyme Immunoassay (CLIA)
        5. Liquid Chromatography Mass
        6. Spectrometry (LC-MS)
      3. Europe Renal Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Diagnostic Laboratory
        3. Others
      4. U.K.
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      5. Germany
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      6. France
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      7. Spain
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      8. Italy
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      9. Russia
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      10. Nordic
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      11. Benelux
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      12. Rest of Europe
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
    3. APAC
      1. APAC Renal Biomarkers Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
      2. APAC Renal Biomarkers Market By Diagnostic Technique 2022-2034 (USD MILLION/ Units)
        1. Enzyme-linked Immunosorbent Assay
        2. Colorimetric Assay
        3. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        4. Chemiluminescent Enzyme Immunoassay (CLIA)
        5. Liquid Chromatography Mass
        6. Spectrometry (LC-MS)
      3. APAC Renal Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Diagnostic Laboratory
        3. Others
      4. China
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      5. Korea
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      6. Japan
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      7. India
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      8. Australia
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      9. Taiwan
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      10. South East Asia
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      11. Rest of Asia-Pacific
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
    4. Middle East and Africa
      1. Middle East and Africa Renal Biomarkers Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
      2. Middle East and Africa Renal Biomarkers Market By Diagnostic Technique 2022-2034 (USD MILLION/ Units)
        1. Enzyme-linked Immunosorbent Assay
        2. Colorimetric Assay
        3. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        4. Chemiluminescent Enzyme Immunoassay (CLIA)
        5. Liquid Chromatography Mass
        6. Spectrometry (LC-MS)
      3. Middle East and Africa Renal Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Diagnostic Laboratory
        3. Others
      4. UAE
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      5. Turkey
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      6. Saudi Arabia
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      7. South Africa
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      8. Egypt
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      9. Nigeria
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      10. Rest of MEA
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
    5. LATAM
      1. LATAM Renal Biomarkers Market By Biomarker Type 2022-2034 (USD MILLION/ Units)
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
      2. LATAM Renal Biomarkers Market By Diagnostic Technique 2022-2034 (USD MILLION/ Units)
        1. Enzyme-linked Immunosorbent Assay
        2. Colorimetric Assay
        3. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        4. Chemiluminescent Enzyme Immunoassay (CLIA)
        5. Liquid Chromatography Mass
        6. Spectrometry (LC-MS)
      3. LATAM Renal Biomarkers Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Hospital
        2. Diagnostic Laboratory
        3. Others
      4. Brazil
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      5. Mexico
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      6. Argentina
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      7. Chile
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      8. Colombia
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
      9. Rest of LATAM
        1. Functional Biomarker
        2. Up-regulated Protein
        3. Other Biomarker Types
        4. Enzyme-linked Immunosorbent Assay
        5. Colorimetric Assay
        6. Particle-enhanced Turbidimetric Immunoassay (PETIA)
        7. Chemiluminescent Enzyme Immunoassay (CLIA)
        8. Liquid Chromatography Mass
        9. Spectrometry (LC-MS)
        10. Hospital
        11. Diagnostic Laboratory
        12. Others
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.